Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18309
Abstract: Thrombopoietin receptor agonists (TPO‐RA) are a valid therapy for immune thrombocytopenia (ITP), due to megakaryocyte stimulation and (poorly characterised) immune‐modulatory effects. The spleen is pivotal in the pathogenesis of ITP, yet little is known on… read more here.
Keywords: receptor agonists; thrombopoietin receptor; immune thrombocytopenia; splenic regulatory ... See more keywords